Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

101.09 -0.04 (-0.04%)
Streaming Delayed Price Updated: 10:55 AM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,820,578
Open 101.13
Bid (Size) 101.09 (300)
Ask (Size) 101.10 (1,400)
Prev. Close 101.13
Today's Range 101.05 - 101.17
52wk Range 38.81 - 101.87
Shares Outstanding 171,948,769
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Overrated Stocks That Concern Us
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro... 
Via StockStory
News headline image
Here's Why Grail Soared, Again, in November ↗
A combination of operational improvements and developments at its key rival bolstered the stock recently. 
Via The Motley Fool

Performance

YTD
+77.6%
+77.6%
1 Month
+45.3%
+45.3%
3 Month
+96.6%
+96.6%
6 Month
+85.9%
+85.9%
1 Year
+57.6%
+57.6%

More News

Read More
News headline image
This Top Dividend King Just Became an Even Better Buy ↗
Via The Motley Fool
News headline image
Halper Sadeh LLC Encourages SEE, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
Exact Sciences Stock Soars To 4-Year High Even As Wall Street Piles On Downgrades After Abbott Deal — Retail Traders Take Profits ↗
Via Stocktwits
Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover ↗
Via Stocktwits
News headline image
Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium
From Exact Sciences Corp.
Via Business Wire
News headline image
Unusual volume stocks are being observed in Monday's session. ↗
Via Chartmill
News headline image
Q3 Earnings Highs And Lows: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Immuno-Oncology Stocks
Via StockStory
Topics Artificial Intelligence
News headline image
Halper Sadeh LLC Encourages EXAS, NVRI, MRUS Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More ↗
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
Why Exact Sciences Rallied Over 50% This Week ↗
Via The Motley Fool
News headline image
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Exact Sciences Corporation (Nasdaq – EXAS)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Why Exact Sciences Stock Surged Today ↗
Via The Motley Fool
News headline image
Tech Stocks Fall Despite Nvidia's Beat, Walmart Jumps 6%: What's Moving Markets Thursday? ↗
Via Benzinga
News headline image
Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday ↗
Via Benzinga
News headline image
Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics ↗
Via Benzinga
News headline image
EXAS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Exact Sciences Corporation is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Abbott To Acquire Exact Sciences For Up To $23B ↗
Via Stocktwits
News headline image
Why Exact Sciences Stock Blasted Nearly 24% Higher Today ↗
Via The Motley Fool
News headline image
2 Surging Stocks with Competitive Advantages and 1 We Question
Via StockStory
News headline image
Exact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome’s Blood-Based Colorectal Cancer Screening Tests
From Exact Sciences Corp.
Via Business Wire
News headline image
The 5 Most Interesting Analyst Questions From Exact Sciences’s Q3 Earnings Call
Via StockStory
Topics Earnings
News headline image
2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗
Via The Motley Fool

Frequently Asked Questions

Is Exact Sciences Corporation - Common Stock publicly traded?
Yes, Exact Sciences Corporation - Common Stock is publicly traded.
What exchange does Exact Sciences Corporation - Common Stock trade on?
Exact Sciences Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exact Sciences Corporation - Common Stock?
The ticker symbol for Exact Sciences Corporation - Common Stock is EXAS on the Nasdaq Stock Market
What is the current price of Exact Sciences Corporation - Common Stock?
The current price of Exact Sciences Corporation - Common Stock is 101.09
When was Exact Sciences Corporation - Common Stock last traded?
The last trade of Exact Sciences Corporation - Common Stock was at 12/05/25 10:55 AM ET
What is the market capitalization of Exact Sciences Corporation - Common Stock?
The market capitalization of Exact Sciences Corporation - Common Stock is 17.38B
How many shares of Exact Sciences Corporation - Common Stock are outstanding?
Exact Sciences Corporation - Common Stock has 17B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.